ICICI Prudential Mutual Fund has crossed the 5% shareholding threshold in Rainbow Childrens Medicare Ltd following a strategic acquisition on March 19, 2026. The mutual fund acquired 1,60,949 shares through open market purchases, triggering mandatory disclosure requirements under SEBI's Substantial Acquisition of Shares and Takeovers Regulations 2011.

Shareholding Details

The acquisition has resulted in a notable increase in ICICI Prudential Mutual Fund's stake in the healthcare company. The fund's total shareholding has moved from 4.92% to 5.08% of the company's paid-up capital.

Company Capital Structure

Rainbow Childrens Medicare Ltd maintains a stable capital structure following the transaction. The company's equity share capital remains unchanged at ₹ 1,01,55,91,560, comprising 10,15,59,156 shares with a face value of ₹10 each.

Investment Perspective

ICICI Prudential Mutual Fund has clarified that the shareholding across its various schemes and investment strategies is maintained from an investment perspective. The fund explicitly stated that the acquisition is not aimed at seeking any controlling interest in Rainbow Childrens Medicare Ltd.

Regulatory Compliance

The disclosure was made in compliance with Regulation 29(1) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations 2011. The notification was filed by Rakesh Shetty, Chief Compliance Officer & Company Secretary of ICICI Prudential Asset Management Company Limited, on March 20, 2026.

Rainbow Childrens Medicare Ltd's shares are listed on both BSE Limited and National Stock Exchange of India Limited. The mutual fund confirmed that it does not belong to the promoter or promoter group of the target company.

Rainbow Children's Medicare Limited has announced the grant of 1,00,000 stock options to its eligible employees under the Employee Stock Option Scheme 2025. The Nomination and Remuneration Committee approved this grant during its meeting held on January 28, 2026, as disclosed under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Stock Option Grant Details

The comprehensive details of the stock option grant are structured as follows:

Vesting and Exercise Terms

The stock options come with specific vesting and exercise conditions designed to align employee interests with company performance. The vested stock options can be exercised within a maximum period of 2 years from the date of each vesting. The vesting schedule allows stock options to vest after a minimum period of 1 year but not later than the maximum period of 10 years from the grant date.

Pricing Structure

The exercise price for the granted options has been determined using a market-linked pricing formula. The options were granted at an exercise price set at a discount of not more than 20% on the latest available closing price of the company's equity shares on the National Stock Exchange of India Limited, which is the stock exchange with the highest trading volume for the company's shares.

Previous Grant Cancellations

The company also reported cancellations from previous grants, with 6,430 stock options that were granted during the Nomination and Remuneration Committee meeting held on July 26, 2025, now standing cancelled. These cancellations occurred due to the exit of respective employees prior to completion of the vesting period, demonstrating the performance-linked nature of the scheme.

Regulatory Compliance

The Employee Stock Option Scheme 2025 operates in full compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The disclosure was made in accordance with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, ensuring transparency and regulatory adherence in the stock option grant process.